Last reviewed · How we verify

NCT06009601

The Relationship Between Pectus Deformities and Spinal Pathologies

Completed Last updated 24 August 2023
What this trial tests

trial testing Pectus Study Form in Pectus Deformity of Chest in 40 participants. Completed in 28 April 2023.

Timeline
9 March 2023
Primary endpoint
9 April 2023
28 April 2023

Quick facts

Lead sponsorGaziosmanpasa Research and Education Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date9 March 2023
Primary completion9 April 2023
Estimated completion28 April 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gaziosmanpasa Research and Education Hospital

Who can join

Adults 3 to 18, any sex, with Pectus Deformity of Chest or Spinal Deformity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pectus deformities are common anterior chest wall pathologies. Pectus excavatum is the most common chest deformity with an incidence of 0.1-0.3%. Although the incidence of adolescent idiopathic scoliosis (AIS) is 0.2-3% in the community, some studies show that this rate rises to 17.61-25.58% when it is associated with pectus deformity. While the pectus excavatum rotates the heart to the left with its ribs and cartilages, it pushes the thoracic vertebra to the right side with the internal counterforce created by the heart, which has been shown to push the spine to the right with an asymmetric horizontal force in scoliosis patients with pectus deformity. Based on this, in study, investigators aimed to determine whether there is any relationship between pectus deformities and spinal pathologies, and if there is a relationship, with which pathology it is most common, whether the type of scoliosis seen in pectus deformities with a prominent scoliosis prevalence is a pectus-specific curve, and whether this curve seen in scoliosis is associated with pectus. To determine whether there is a footprint or not.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Gaziosmanpasa Research and Education Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06009601.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing